Synopsis
0
CEP/COS
0
JDMF
0
VMF
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Related Excipient Companies
SPI Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Faran Shimi Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Healthcare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nanjing Well Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Anhui Sunhere Pharmaceutical Excipients Co.,Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DFE Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Chemicals
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ideal Cures Pvt Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ingredion Pharma Solutions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kerry
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Microlex e.U
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pharmatrans-Sanaq
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pluviaendo
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Prachin Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Roquette
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Seppic
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Shanghai Shenmei Pharmaceutical Technology Co., Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Fillers, Diluents & Binders
Disintegrants & Superdisintegrants
Direct Compression
Granulation
Thickeners and Stabilizers
Lubricants & Glidants
Co-Processed Excipients
Controlled & Modified Release
Chewable & Orodispersible Aids
Taste Masking
Coating Systems & Additives
Emulsifying Agents
Rheology Modifiers
Parenteral
Film Formers & Plasticizers
API Stability Enhancers
Digital Content
NEWS #PharmaBuzz
Global Sales Information
US Medicaid Prescriptions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
77
PharmaCompass offers a list of Chlorzoxazone API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Chlorzoxazone manufacturer or Chlorzoxazone supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Chlorzoxazone manufacturer or Chlorzoxazone supplier.
PharmaCompass also assists you with knowing the Chlorzoxazone API Price utilized in the formulation of products. Chlorzoxazone API Price is not always fixed or binding as the Chlorzoxazone Price is obtained through a variety of data sources. The Chlorzoxazone Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Chlorzoxazone manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Chlorzoxazone, including repackagers and relabelers. The FDA regulates Chlorzoxazone manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Chlorzoxazone API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Chlorzoxazone manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Chlorzoxazone supplier is an individual or a company that provides Chlorzoxazone active pharmaceutical ingredient (API) or Chlorzoxazone finished formulations upon request. The Chlorzoxazone suppliers may include Chlorzoxazone API manufacturers, exporters, distributors and traders.
click here to find a list of Chlorzoxazone suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Chlorzoxazone DMF (Drug Master File) is a document detailing the whole manufacturing process of Chlorzoxazone active pharmaceutical ingredient (API) in detail. Different forms of Chlorzoxazone DMFs exist exist since differing nations have different regulations, such as Chlorzoxazone USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Chlorzoxazone DMF submitted to regulatory agencies in the US is known as a USDMF. Chlorzoxazone USDMF includes data on Chlorzoxazone's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Chlorzoxazone USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Chlorzoxazone suppliers with USDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Chlorzoxazone Drug Master File in Korea (Chlorzoxazone KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Chlorzoxazone. The MFDS reviews the Chlorzoxazone KDMF as part of the drug registration process and uses the information provided in the Chlorzoxazone KDMF to evaluate the safety and efficacy of the drug.
After submitting a Chlorzoxazone KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Chlorzoxazone API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Chlorzoxazone suppliers with KDMF on PharmaCompass.
A Chlorzoxazone written confirmation (Chlorzoxazone WC) is an official document issued by a regulatory agency to a Chlorzoxazone manufacturer, verifying that the manufacturing facility of a Chlorzoxazone active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Chlorzoxazone APIs or Chlorzoxazone finished pharmaceutical products to another nation, regulatory agencies frequently require a Chlorzoxazone WC (written confirmation) as part of the regulatory process.
click here to find a list of Chlorzoxazone suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Chlorzoxazone as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Chlorzoxazone API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Chlorzoxazone as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Chlorzoxazone and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Chlorzoxazone NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Chlorzoxazone suppliers with NDC on PharmaCompass.
Chlorzoxazone Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Chlorzoxazone GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Chlorzoxazone GMP manufacturer or Chlorzoxazone GMP API supplier for your needs.
A Chlorzoxazone CoA (Certificate of Analysis) is a formal document that attests to Chlorzoxazone's compliance with Chlorzoxazone specifications and serves as a tool for batch-level quality control.
Chlorzoxazone CoA mostly includes findings from lab analyses of a specific batch. For each Chlorzoxazone CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Chlorzoxazone may be tested according to a variety of international standards, such as European Pharmacopoeia (Chlorzoxazone EP), Chlorzoxazone JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Chlorzoxazone USP).
